ChemicalBook >> CAS DataBase List >>LOXIGLUMIDE
LOXIGLUMIDE
- CAS No.
- 107097-80-3
- Chemical Name:
- LOXIGLUMIDE
- Synonyms
- cr1505;CS-162;anoicacid;ntanoicacid;(+-)--5-oxo;LOXIGLUMIDE;Loxiglumide, >98%;LoxigluMide (CR1505);Loxiglumide >=97% (HPLC);d,l-4-(3,4-dichlorobenzoylamino)-5-(n-3-methoxypropylpentylamino)-5-oxo-pent
- CBNumber:
- CB0326090
- Molecular Formula:
- C21H30Cl2N2O5
- Molecular Weight:
- 461.38
- MDL Number:
- MFCD00866772
- MOL File:
- 107097-80-3.mol
- MSDS File:
- SDS
Last updated:2023-06-30 15:45:59
| Melting point | 113-115℃ |
|---|---|
| Boiling point | 632.2±55.0 °C(Predicted) |
| Density | 1.233±0.06 g/cm3(Predicted) |
| storage temp. | 2-8°C |
| solubility | DMSO: ≥5mg/mL |
| pka | pKa ~5(at 25℃) |
| form | powder |
| color | white to beige |
| CAS DataBase Reference | 107097-80-3 |
| FDA UNII | 77MPX3N42I |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |  GHS07 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Warning | |||||||||
| Hazard statements | H302-H315-H319-H335 | |||||||||
| Precautionary statements | P261-P305+P351+P338 | |||||||||
| Hazard Codes | Xn | |||||||||
| Risk Statements | 22 | |||||||||
| WGK Germany | 3 | |||||||||
| NFPA 704 |
|
LOXIGLUMIDE price More Price(20)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich | SML0130 | Loxiglumide ≥97% (HPLC) | 107097-80-3 | 10mg | $96.1 | 2024-03-01 | Buy |
| Sigma-Aldrich | SML0130 | Loxiglumide ≥97% (HPLC) | 107097-80-3 | 50mg | $313 | 2024-03-01 | Buy |
| Cayman Chemical | 25534 | Loxiglumide ≥98% | 107097-80-3 | 5mg | $56 | 2024-03-01 | Buy |
| Cayman Chemical | 25534 | Loxiglumide ≥98% | 107097-80-3 | 10mg | $87 | 2024-03-01 | Buy |
| Cayman Chemical | 25534 | Loxiglumide ≥98% | 107097-80-3 | 25mg | $201 | 2024-03-01 | Buy |
LOXIGLUMIDE Chemical Properties,Uses,Production
Uses
Loxiglumide is a CCK1 antagonist. Suppresses CCK-induced proliferation of acinar cells. Inhibits pancreatic secretion of digestive enzymes. Active in vivo.
Definition
ChEBI: Loxiglumide is an organic molecular entity.
Biochem/physiol Actions
Loxiglumide is a small-molecule antagonist of the cholecystokinin receptor CCKA. Loxiglumide inhibits pancreatic secretion of digestive enzymes, and also blocks CCK-induced gastric secretions and emptying.
Safety Profile
A poison by intravenous. Moderately toxic by ingestion, intraperitoneal, and subcutaneous routes. When heated to decomposition it emits toxic vapors of NOx and Cl-.
storage
Store at -20°C
LOXIGLUMIDE Preparation Products And Raw materials
Raw materials
Preparation Products
Global( 71)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 | ivan@atkchemical.com | China | 32480 | 60 |
| BOC Sciences | +1-631-485-4226 | inquiry@bocsci.com | United States | 19553 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 | marketing@targetmol.com | United States | 19892 | 58 |
| HANGZHOU CLAP TECHNOLOGY CO.,LTD | 86-571-88216897,88216896 13588875226 | sales@hzclap.com | CHINA | 6313 | 58 |
| Zhejiang J&C Biological Technology Co.,Limited | +1-2135480471 +1-2135480471 | sales@sarms4muscle.com | China | 10523 | 58 |
| InvivoChem | +1-708-310-1919 +1-13798911105 | sales@invivochem.cn | United States | 6393 | 58 |
| LEAP CHEM CO., LTD. | +86-852-30606658 | market18@leapchem.com | China | 24738 | 58 |
| Hangzhou MolCore BioPharmatech Co.,Ltd. | +86-057181025280; +8617767106207 | sales@molcore.com | China | 49739 | 58 |
| ShenZhen Trendseen Biological Technology Co.,Ltd. | 13417589054 | trendseenbio@gmail.com | China | 11681 | 58 |
| Shanghai Acmec Biochemical Technology Co., Ltd. | +undefined18621343501 | product@acmec-e.com | China | 33349 | 58 |
107097-80-3(LOXIGLUMIDE)Related Search:
4-[(3,4-dichlorobenzoyl)amino]-5-[3-methoxypropyl(pentyl)amino]-5-oxopentanoic acid
4-[(3,4-dichlorophenyl)carbonylamino]-5-[3-methoxypropyl(pentyl)amino]-5-oxo-pentanoic acid
5-[amyl(3-methoxypropyl)amino]-4-[(3,4-dichlorobenzoyl)amino]-5-keto-valeric acid
LoxigluMide (CR1505)
LOXIGLUMIDE
(+-)-4-((3,4-dichlorobenzoyl)amino)-5-((3-methoxypropyl)pentylamino)-5-oxope
(+-)--5-oxo
anoicacid
cr1505
d,l-4-(3,4-dichlorobenzoylamino)-5-(n-3-methoxypropylpentylamino)-5-oxo-pent
ntanoicacid
pentanoicacid,4-((3,4-dichlorobenzoyl)amino)-5-((3-methoxypropyl)pentylamino)
CS-162
Loxiglumide, >98%
Pentanoic acid, 4-[(3,4-dichlorobenzoyl)amino]-5-[(3-methoxypropyl)pentylamino]-5-oxo-
Loxiglumide >=97% (HPLC)
CR1505,CR 1505,CCK Receptor,Inhibitor,Loxiglumide,inhibit,Cholecystokinin Receptor
4-(3,4-Dichlorobenzamido)-5-((3-methoxypropyl)(pentyl)amino)-5-oxopentanoicacid
107097-80-3
C21H30Cl2N2O5
Inhibitors